Ambar Protein Industries reported a substantial improvement in profitability for the first quarter of FY27, with net profit after tax rising to ₹3.75 crore compared to ₹0.75 crore in the corresponding period of FY26. This represents a year-on-year increase of over 400%, signaling a recovery in the company’s bottom line despite modest headwinds on the top line.

Revenue from operations for the quarter ended June 30, 2026, stood at ₹113.45 crore, a slight decline from ₹117.27 crore recorded in Q1FY25. For the full fiscal year ended March 31, 2026, the company logged total income from operations of ₹500.66 crore.

Financial Performance

The company’s pre-tax profit for the quarter was ₹5.11 crore, up from ₹1.47 crore in the previous year. No exceptional or extraordinary items were reported in the statement of profit and loss for either period. Earnings per share (basic and diluted) increased to ₹6.53 per equity share of face value ₹10 each, compared to ₹1.30 in Q1FY25.

What the Numbers Show

The divergence between revenue and profit trends highlights an improvement in operational efficiency or cost management during the quarter. While revenue contracted by approximately 3.3% year-on-year, net profit expanded more than fourfold. This suggests that fixed costs were better absorbed or input costs declined relative to selling prices, allowing margins to expand despite lower sales volume. The absence of exceptional items indicates that the profit growth was driven by core operational performance rather than one-off gains.

Pradeep Kumar Chunilal Khetani, a promoter belonging to the promoter group of Ambar Protein Industries Limited , has increased his shareholding in the company through an open market acquisition. The transaction involved the purchase of 18,187 equity shares, accounting for 0.32% of the total paid-up capital. The acquisition was executed on June 29 and June 30, 2026.

Prior to this transaction, Khetani held 737,651 equity shares, representing 12.83% of the company's share capital. With the addition of the latest purchase, his total holding now stands at 755,838 equity shares. This revised stake translates to 13.14% of the total voting capital of Ambar Protein Industries Limited.

The disclosure was submitted to BSE Limited on July 1, 2026, under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation mandates the disclosure of substantial acquisition of shares by promoters or persons acting in concert.

The equity share capital of Ambar Protein Industries Limited remains at INR 5,75,00,000, consisting of 57,50,000 equity shares of INR 10 each. There was no change in the total diluted share or voting capital of the target company following the said acquisition.

Shareholding Details

The following table outlines the changes in Khetani's shareholding: